Neurocrine Biosciences Inc reports results for the quarter ended in September 30 - Earnings Summary

Neurocrine Biosciences

30/10/2024 13:20

* Neurocrine Biosciences Inc  NBIX.OQ  reported quarterly
adjusted
earnings of $1.24​​ per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of 82 cents.  The mean expectation of twenty
seven analysts for the quarter was for earnings of $1.51 per
share. Wall Street expected results to range from $1.26 
to $2.12 per share.
    * Revenue rose 24.7% to $622.10 million from a year ago;
analysts
expected $600.63 million. 
    * Neurocrine Biosciences Inc's reported EPS for the quarter
was
$1.24​.
    * The company reported quarterly net income of $129.8
million.
    * Neurocrine Biosciences Inc shares had risen by 0.8% this
quarter and lost 11.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 18.7%
in the last three months.​ 
    * In the last 30 days, four analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 24 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Neurocrine
Biosciences Inc is $168.00 
This summary was machine generated from LSEG data October 30 at
01:20 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      1.51           1.24           Missed
 Jun. 30 2024      1.05           0.63           Missed
 Mar. 31 2024      1.01           0.42           Missed
 Dec. 31 2023      1.15           1.44           Beat